"Die Brustzentrum Ostschweiz AG bietet ein umfassendes Angebot zur Behandlung von bösartigen und gutartigen Brusterkrankungen für Patientinnen und Patienten aller Versicherungsklassen. Das spezialisierte interdisziplinäre Team arbeitet auf wissenschaftlich höchstem Niveau und setzt gleichzeitig den Schwerpunkt auf eine individuelle, kontinuierliche und menschliche Betreuung von der Diagnose zur Therapie bis zur Nachbehandlung."

During the past decade, Brustzentrum Ostschweiz conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Brustzentrum Ostschweiz" #1 sponsor was "Swiss Group for Clinical Cancer Research" with 3 trials, followed by "Constanze Elfgen" with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored, "Klinik Hirslanden, Zurich" with 1 trials sponsored and "University Hospital, Basel, Switzerland" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Brustzentrum Ostschweiz" #1 collaborator was "Austrian Breast Cancer Study Group" with 1 trials as a collaborator, "ETOP IBCSG Partners Foundation" with 1 trials as a collaborator and "The Belgian Society of Medical Oncology" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Brustzentrum Ostschweiz" are "Breast Cancer" (3 trials), "Bone Metastases" (1 trials), "Breast Neoplasms" (1 trials), "Early Breast Cancer" (1 trials) and "Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Brustzentrum Ostschweiz" in a lesser frequency.

Most popular intervention types in "Brustzentrum Ostschweiz" are "Drug" (3 trials), "Procedure" (2 trials), "Behavioral" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abemaciclib" (1 trials), "Activity program" (1 trials), "Control" (1 trials), "Denosumab (reduced dosing)" (1 trials) and "Denosumab (standard dosing)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Brustzentrum Ostschweiz" are 4 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Brustzentrum Ostschweiz". 1 are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Brustzentrum Ostschweiz, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Brustzentrum Ostschweiz, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".